The vaccine produced by American pharmaceutical giant Pfizer has recorded 95% efficacy and safety level. On Monday, a vaccine manufactured by another pharmaceutical company, Moderna, reported similar successes.
The company expects to submit documentation to the Food and Drug Administration of the US and other institutions, to obtain an emergency approval within the next few days.
Pfizer’s phase 3 trials involved 43,000 people from around the world. This sent hope across the globe that a successful vaccine will be in the market in the near future.